NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 230 filers reported holding NEKTAR THERAPEUTICS in Q3 2022. The put-call ratio across all filers is 0.14 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $33,999 | +3.5% | 57,083 | 0.0% | 0.00% | – |
| Q2 2023 | $32,834 | +81985.0% | 57,083 | 0.0% | 0.00% | -100.0% |
| Q1 2023 | $40 | -93.3% | 57,083 | -78.5% | 0.00% | -91.7% |
| Q4 2022 | $601 | -99.9% | 265,827 | -0.5% | 0.01% | -33.3% |
| Q3 2022 | $855,000 | -53.5% | 267,063 | -44.8% | 0.02% | -62.5% |
| Q2 2022 | $1,838,000 | -27.9% | 483,788 | +2.3% | 0.05% | -20.0% |
| Q1 2022 | $2,548,000 | +44.8% | 472,688 | +262.9% | 0.06% | +106.9% |
| Q4 2021 | $1,760,000 | +0.9% | 130,266 | +34.1% | 0.03% | +3.6% |
| Q3 2021 | $1,744,000 | -42.9% | 97,113 | -45.4% | 0.03% | -51.7% |
| Q2 2021 | $3,052,000 | +931.1% | 177,859 | +922.1% | 0.06% | +625.0% |
| Q4 2020 | $296,000 | -82.3% | 17,401 | -82.8% | 0.01% | -89.0% |
| Q3 2020 | $1,675,000 | -24.1% | 100,972 | +6.0% | 0.07% | -33.0% |
| Q2 2020 | $2,207,000 | +210.8% | 95,287 | +139.6% | 0.11% | +70.3% |
| Q1 2020 | $710,000 | -76.4% | 39,774 | -71.5% | 0.06% | -52.6% |
| Q4 2019 | $3,012,000 | +1176.3% | 139,554 | +979.1% | 0.14% | +1587.5% |
| Q3 2019 | $236,000 | -37.6% | 12,932 | +108.8% | 0.01% | -20.0% |
| Q3 2018 | $378,000 | -92.9% | 6,193 | -94.3% | 0.01% | -94.6% |
| Q2 2018 | $5,326,000 | +2733.0% | 109,071 | +696.1% | 0.18% | +3600.0% |
| Q1 2016 | $188,000 | +26.2% | 13,700 | +14.8% | 0.01% | +25.0% |
| Q2 2015 | $149,000 | -17.7% | 11,933 | +2.0% | 0.00% | -33.3% |
| Q4 2014 | $181,000 | – | 11,698 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 3,500,000 | $60,060,000 | 2.02% |
| ACT CAPITAL MANAGEMENT, LLC | 161,500 | $2,772,000 | 1.42% |
| Rhenman & Partners Asset Management AB | 950,000 | $16,302,000 | 1.11% |
| MAVERICK CAPITAL LTD | 5,761,073 | $98,860,000 | 0.93% |
| Birchview Capital, LP | 72,000 | $1,236,000 | 0.74% |
| Bellevue Group AG | 4,101,404 | $70,380,000 | 0.69% |
| CM Management, LLC | 50,000 | $858,000 | 0.62% |
| Duquesne Family Office | 1,000,000 | $17,160,000 | 0.42% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 373,368 | $6,407,000 | 0.33% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 67,000 | $1,149,000 | 0.30% |